GlassScriptPhysician profile
Suzanne H Staudinger
NPI 1861572737
$2,459.49
in general payments reported to CMS, 2019-2025
22 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $76.92 · 2021: $456 · 2022: $603 · 2023: $259 · 2024: $419 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919 · Education: $23.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.94 |
| Education | $23.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $771.23 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $370.10 | 2019-2024 | |
| Glaxosmithkline, LLC. | $208.97 | 2019-2023 | Arexvy, Bexsero, Shingrix |
| Otsuka America Pharmaceutical, INC. | $150.02 | 2019-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.03 | 2023-2025 | Jardiance |
| Mylan Specialty L.P. | $124.29 | 2021-2023 | Yupelri |
| Pfizer INC. | $122.18 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $102.25 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $90.41 | 2022 | |
| Daiichi Sankyo INC. | $49.31 | 2024-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $46.43 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $43.82 | 2020-2021 | |
| Sanofi Pasteur INC. | $39.87 | 2021-2024 | |
| Novo Nordisk INC | $30.78 | 2021 | |
| Kyowa Kirin, INC. | $28.40 | 2024 | Crysvita |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28.23 | 2024 | Intellis Adaptivestim |
| Sunovion Pharmaceuticals INC. | $25.15 | 2021 | |
| Medtronic Minimed, INC. | $23.71 | 2019 | |
| Alk-Abello, INC | $20.56 | 2024 | Odactra, Grastek, Ragwitek |
| Bayer Healthcare Pharmaceuticals INC. | $18.68 | 2022 | |
| Shire North American Group INC | $15.95 | 2019 | |
| Eisai INC. | $15.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Staudinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.